What is B. Riley's Forecast for Core Scientific Q1 Earnings?

Core Scientific, Inc. (NASDAQ:CORZ - Free Report) - Investment analysts at B. Riley issued their Q1 2027 earnings per share (EPS) estimates for shares of Core Scientific in a research report issued on Thursday, May 8th. B. Riley analyst N. Giles anticipates that the company will earn $0.08 per share for the quarter. The consensus estimate for Core Scientific's current full-year earnings is $0.52 per share. B. Riley also issued estimates for Core Scientific's FY2027 earnings at $0.33 EPS.

A number of other analysts have also recently commented on the company. Oppenheimer assumed coverage on Core Scientific in a research note on Wednesday. They set an "outperform" rating and a $15.00 target price for the company. HC Wainwright reiterated a "buy" rating and issued a $17.00 price objective on shares of Core Scientific in a report on Tuesday, March 11th. Compass Point reduced their price objective on Core Scientific from $26.00 to $20.00 and set a "buy" rating on the stock in a research note on Tuesday, February 25th. Keefe, Bruyette & Woods began coverage on Core Scientific in a research report on Monday, January 27th. They set an "outperform" rating and a $22.00 price objective for the company. Finally, Craig Hallum started coverage on shares of Core Scientific in a research report on Tuesday, January 21st. They issued a "buy" rating and a $24.00 price target for the company. Sixteen equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, Core Scientific presently has an average rating of "Buy" and a consensus target price of $18.81.

Core Scientific Price Performance

CORZ traded up $0.19 during trading on Monday, reaching $10.51. 13,915,042 shares of the company's stock were exchanged, compared to its average volume of 13,080,526. The stock has a market capitalization of $3.13 billion, a P/E ratio of -1.94 and a beta of 6.66. The company's fifty day simple moving average is $7.98 and its 200-day simple moving average is $12.03. Core Scientific has a 1 year low of $3.58 and a 1 year high of $18.63.

Core Scientific (NASDAQ:CORZ - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported ($0.10) EPS for the quarter, topping the consensus estimate of ($0.12) by $0.02. The company had revenue of $79.53 million for the quarter, compared to analyst estimates of $92.04 million. The company's quarterly revenue was down 55.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.78 earnings per share.

Hedge Funds Weigh In On Core Scientific

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Wellington Shields & Co. LLC bought a new stake in shares of Core Scientific in the 4th quarter worth $26,000. First Horizon Advisors Inc. acquired a new position in Core Scientific during the fourth quarter worth about $34,000. Newbridge Financial Services Group Inc. bought a new stake in Core Scientific in the fourth quarter worth about $42,000. Vestcor Inc bought a new stake in Core Scientific in the fourth quarter worth about $66,000. Finally, State of Wyoming acquired a new position in shares of Core Scientific in the 1st quarter worth approximately $34,000.

Insider Buying and Selling

In related news, Director Jordan Levy acquired 62,500 shares of the stock in a transaction that occurred on Thursday, March 6th. The shares were acquired at an average price of $8.01 per share, for a total transaction of $500,625.00. Following the completion of the purchase, the director now directly owns 306,887 shares of the company's stock, valued at $2,458,164.87. The trade was a 25.57% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Todd A. Becker sold 134,250 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $10.75, for a total value of $1,443,187.50. Following the sale, the director now directly owns 195,687 shares in the company, valued at approximately $2,103,635.25. The trade was a 40.69% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.40% of the company's stock.

Core Scientific Company Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.